This new report provides analysis of CA 19-9 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
France, Germany, Italy, Japan, Spain, UK, USA
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Cancer Clinics
SIMILAR MARKET STUDIES
This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
December 2013 | $5500 | View Details >>
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country ...
October 2015 | $3500 | View Details >>
Notes: Sales, means the sales volume of Central Nervous System (CNS) Biomarkers Revenue, means the sales value of Central Nervous System (CNS) Biomarkers This report studies sales (consumption) of Central Nervous System (CNS) Biomarkers in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these ...
October 2016 | $3900 | View Details >>
Summary This comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years. The report explores business and technological trends in the Italian coagulation testing ...
January 2014 | $3950 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research